Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 20mg/vial
Product details
Registration number: SIN17380P
Classification: Prescription Only
Active ingredients: Octreotide acetate equivalent to Octreotide
Strength: 20mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION,EXTENDED RELEASE
Route: INTRAMUSCULAR
Registrant: SCIGEN PTE. LTD.
ATC code: H01CB02
HSA approval date: 31 October 2025
Manufacturer(s):
- Pharmathen International S.A. (Powder and Solvent)
- Pharmathen International S.A. (Powder and Solvent)
Manufacturing country/countries: GREECE
What are the HSA registration number and classification for Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 20mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17380P
Classification: Prescription Only
What active ingredients and strength are recorded for Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 20mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Octreotide acetate equivalent to Octreotide
Strength: 20mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 20mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION,EXTENDED RELEASE
Route: INTRAMUSCULAR
Who is the recorded registrant for Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 20mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: SCIGEN PTE. LTD.
Which manufacturers and countries are listed for Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 20mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Pharmathen International S.A. (Powder and Solvent)
- Pharmathen International S.A. (Powder and Solvent)
Manufacturing country/countries: GREECE
Where can I look up Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 20mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17380P or the exact product name Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 20mg/vial. The general register link does not preselect this product.
What are the source dates for this Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 20mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 20mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17380P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)